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Abstract
Stem cell-based therapies raise hope for cell replacement and provide opportunity for cardiac regenerative
medicine and tumor therapy. Extracellular vesicles are a membrane-enclosed intercellular delivery system with the
potential to improve the therapeutic efficacy of the treatment of a variety of disorders. As the incidence of breast
cancer continues to rise, radiotherapy has emerged as a leading treatment modality. Radiotherapy also increases
the risk of coronary heart disease and cardiac mortality. In a chest-irradiated mouse model of cardiac injury, we
investigated the effects of local irradiation. We found an increased lethality after 16 Gy irradiation. Importantly,
radio-detoxified LPS (RD-LPS) treatment prolonged the survival significantly. By flow cytometry, we demonstrated
that upon administration of RD-LPS, the number of bone marrow-derived endothelial progenitor cells increased in
the bone marrow and, in particular, in the circulation. Furthermore, mass spectrometry analysis showed that RD-LPS
altered the proteomic composition of bone marrow cell-derived small extracellular vesicles (sEVs). RD-LPS treatment
increased interferon-induced transmembrane protein-3 (IFITM3) expression markedly both in bone marrow cells and
in bone marrow cell-derived small extracellular vesicles. This is the first study to demonstrate that radio-detoxified
LPS treatment induces an increase of circulating endothelial progenitor cells (EPCs) in parallel with a reduced
radiotherapy-related mortality. While the total number of bone marrow-derived extracellular vesicles was
significantly increased 24 h after treatment in the RD-LPS groups, the number of endothelial progenitor cells was
reduced in animals injected with GW4896 (a chemical inhibitor of exosome biogenesis) as compared with controls.
In contrast to these in vivo results, in vitro experiments did not support the effect of sEVs on EPCs. Our data raise
the intriguing possibility that IFITM3 may serve as a marker of the radio-detoxified LPS treatment.
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Introduction
Stem cell therapy holds promise for tissue regeneration,
but the direct replacement of cells in the damaged part
of the tissue is limited and the survival of cells still re-
main questionable [1]. Tissue injury in the heart, lung,
and bone marrow (BM) are among the most important
side effects of breast cancer radiotherapy, which limits
the success of tumor treatment [2–4]. However, the
mechanisms through which ionizing radiation induces
BM injury remains poorly understood [5]. Experimental
models such as the murine radiation-induced cardiomy-
opathy model have proven useful to study the therapeutic
approaches that mitigate radiation injury [6–8].
Several studies have demonstrated the protective effects
of radio-detoxified (gamma irradiation-fragmented) lipo-
polysaccharide (RD-LPS), also referred to as Tolerin [9],
in reducing radiation-induced tissue damage [10]. In the
present study, we investigated for the first time the effects
of RD-LPS in a cardiotoxicity model. We focused on
endothelial progenitor cells (EPCs) and BM cell-derived
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small extracellular vesicles (sEVs) as potential biomarkers
of the RD-LPS effect. BM-derived EPCs have been shown
to have regenerative potential in cardiac diseases both in
preclinical and clinical settings [11]. Recently, circulating
EPCs have been suggested as sensitive and reproducible
markers of endothelial dysfunction caused by ionizing
radiation [12]. In addition, EPCs carry both endothelial
cell markers (such as VEGFR-2 and CD31) [13, 14] and
one or more stem cell antigens such as CD34 [15].
Rapidly accumulating data indicate that cells release
extracellular vesicles (EVs) that mediate cell-cell com-
munication by shuttling lipids, nucleic acids, metabolites,
and proteins to recipient cells [16]. The cargo of EVs is
cell- and disease-type related and confers specific fea-
tures to EVs, mediating their biological functions [17–
19]. In our chest-irradiated mouse model, here we inves-
tigated not only EPCs but also EVs as potential novel
mediators of the effect induced by RD-LPS. In this study,
the biogenesis of EVs was not addressed, and therefore,
we referred to EVs based on their size only [18].
Interferon-induced transmembrane protein 3 (IFITM3)
was initially described in development, apoptosis, cell pro-
liferation, and cell signaling [20, 21]. Also, recently, it was
suggested that ectopic expression of IFITM3 could restrict
infection by viruses [22], by potently inhibiting EV-cell
fusions. Here we addressed the question concerning the
role of IFITM3 in the RD-LPS-induced EPC activation.
Materials and methods
Animals and irradiation
C57BL/6 mice (Charles River Laboratories) were ex-
posed to local 16 Gy chest irradiation as described previ-
ously [23]. Mice were irradiated by a 250-kV X-ray
irradiator (THX-250) using a dose rate of 1.23 Gy/min.
A special lead shield was used to deliver a localized dose
of radiation to the heart region only. Survival was moni-
tored daily, and the experiment was terminated 250 days
post-irradiation.
Histology and morphometric analysis
After 250 days following irradiation, the animals were
sacrificed by cervical dislocation, and the total body weight
and the heart weight were measured. The hearts were
excised and divided into two pieces on the vertical axis
(for DNA isolation and for morphometric analysis). The
tissues were fixed in formalin overnight and embedded in
paraffin. Blocks were sectioned in 4-μm cross-sectioned
slices and stained with Van Gieson staining to determine
the extent of collagen, indicative for fibrosis [24]. The
slides were photographed with Nikon Eclipse 80i, × 20
objective, 10 random fields per slide were taken into con-
sideration. Of these sections, 4 were analyzed per heart. In
total, we analyzed 160 images to evaluate a cross-sectional
area of myocytes by ImageJ program [25, 26].
Detection of the common deletion (3867 bp) in the
mitochondrial genome by qPCR
Total DNA (genomic and mitochondrial together) was
isolated from the heart tissues with the MasterPure
DNA Purification kit (Epicenter) following the manu-
facturer’s instructions. DNA concentration was mea-
sured by spectrophotometry. The amount of deleted
mtDNA copies was estimated by real-time PCR, relative
to the nuclear GAPDH gene. The primers were the
GAPDH-F: TCACCACCATGGAGAAGGC, R: GCTA
AGCAGTTGGTGGTGCA and the delMT-F: TCATTC
TAGCCTCGTACC AACA, R: GAGGTCTGGGTCAT
TTTCGTTA, respectively. QPCR reactions are carried
out using the SYBR Green PCR kit (Bioline), in a
Corbett RG 6000 instrument.
Bone marrow cell apoptosis measurement
BM was isolated from the femora of mice by flushing the
shaft with PBS. For apoptosis measurements, 1 × 106
BMCs per animal were incubated with 3% BSA for 20min.
After washing cells once with cell culture media (RPMI-
1640; Gibco), samples were resuspended in 100 μl of
annexin V binding buffer (BD Pharmingen) containing Lin
cocktail-APC (Miltenyi), and annexin V-FITC (Themo
Fisher Scientific). Before analysis, 1 μl of Topro-3 (1 μg/ml;
Invitrogen) was added to the samples. After washing them
once with PBS, we measured samples by using a FACSCa-
libur (BD Bioscience).
Measurement of EPC differentiation, and DiI-ac-LDL uptake
BM isolated from femurs were collected in endothelial
growing media (EGM)-2 complete medium (Lonza).
BMCs were seeded onto six-well plates at a final density
of 1.5 × 106 cells. Twenty-four hours after seeding, non-
adherent cells were removed and attached cells were fur-
ther cultured at 37 °C and 5% of CO2. Culture media was
changed every 2 days until the first EPC colonies ap-
peared or up to 10 days. EPCs were incubated with 1,
1′-dioctadecyl-3,3,3′,3′- tetramethylindo-carbocyanine-
labeled Ac-LDL (Dil-ac-LDL, Life Technologies), fixed
with 4% paraformaldehyde, and measured by flow cytome-
try (FACSCalibur, BD Bioscience), and for morphological
studies, the stained samples were observed on a fluores-
cent microscope (Zeiss Celldiscoverer). Pictures were
taken with a × 20 objective magnification.
Isolation of small extracellular vesicles
BM cells (BMCs) were cultured in RPMI-1640 (Thermo
Fisher Scientific) supplemented with penicillin (100U/ml),
streptomycin (100 μg/ml), and L-glutamine (2mM) (all
from Sigma) and 2.5% EV-free fetal calf serum (Gibco).
After 24 h, the conditioned medium was centrifuged at
600g for 10min to remove cells. The supernatant was fil-
tered through a 5-μm filter then centrifuged at 2000g for
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30min at 4 °C. Subsequently, supernatants were filtered
again through a 0.8-μm membrane and centrifuged at 12,
500g for 30min at 4 °C. The supernatant was next filtered
through a 0.2-μm filter and pelleted at 100,000g for 70
min at 4 °C using an MLA-55 rotor in an Optima Max XP
ultracentrifuge (Beckman-Coulter). The small EV (sEV)-
enriched pellet was washed once with PBS and resus-
pended in 50 μl PBS. The particles in the resuspended pel-
let were analyzed by tunable resistive pulse sensing (TRPS,
qNano, Izon Sciences) [27]. The protein content of the
sEV-enriched preparations was determined by the Micro-
BCA assay (Pierce). The IFITM3 content was determined
by a commercial ELISA kit (MyBiosource).
Flow cytometry analysis of EPCs and sEVs
BM cells were stained with PE-conjugated anti-CD34-PE
and anti-VEGFR2-PerCP/Cy5.5 antibodies (Sony). Blood
samples were collected into EDTA tubes, red blood cells
were lysed, and anti-CD34-PE and CD31-FITC (Sony) as
well as an isotype control (rat IgG2a, Sony) were used to
detect EPCs. Labeled cells were detected with a flow cyt-
ometer (FACSCalibur, BD Bioscience), and analysis was
performed using the CellQuest and FlowJo softwares.
For sEV analysis, EV-enriched pellet was incubated with
1 μg of 4 μm aldehyde/sulfate latex beads (Invitrogen) for
15min in 50 μl of 0.9% NaCl-HEPES puffer followed by
an overnight incubation at 4 °C with agitation. The reac-
tion was stopped by incubation with 100mM glycine for
30min at room temperature. sEV- or BSA-coated beads
were washed with 1% PBS-BSA, blocked with 0.2% Tropix
I-Block (Thermo) and incubated with either anti-CD81-
PE (BD Bioscience) or isotype control (Armenian hamster
IgG2), anti-CD63-PE (BioLegend), anti-CD107a PerCP/
Cy5.5 (LAMP2, Sony), anti-CD9-PE (Abcam), isotype con-
trol (rat IgG2a) or anti-IFITM3 (ProteinTech), and a goat
anti-rabbit IgG-Cy2 (Abcam) in PBS–BSA 1% for 30min
at 4 °C. Next, the samples were washed and analyzed on a
FACSCalibur flow cytometer (BD Bioscience).
In vivo treatment of mice with GW4869
C57BL/6 mice (10 to 12weeks of age) were randomly
assigned to be injected with PBS, RD-LPS, or GW4869+RD-
LPS (n = 5 per group). GW4869 (Sigma) was dissolved in
DMSO (0.005%) and injected i.p. at a single dose of
25 μg/mouse. Mice in the GW4869+RD-LPS group
were pre-injected i.p. with 20 μg RD-LPS 1 h prior to
the i.p. injection of GW4869. Twenty-four hours later,
the femurs were removed and BMCs were isolated.
Transmission electron microscopy
The sEV pellets were fixed with 4% paraformaldehyde,
washed with PBS, and post-fixed in 1% OsO4 for 30 min
as previously published [28]. After rinsing with distilled
water, pellets were dehydrated in graded ethanol,
including block staining with 1% uranyl-acetate in 50%
ethanol for 30 min, and were embedded in Taab 812.
Overnight polymerization of samples at 60 °C was
followed by sectioning and analysis using a Hitachi 7100
electron microscope (Hitachi Ltd).
Protein identification using LC-MS (MS)
EV pellets were resuspended in 25 μL HPLC water and pro-
teins were extracted as described previously [29]. The result-
ing peptides were desalted using Pierce™ C18 spin columns
(Thermo). Peptides were analyzed using a Waters nanoAC-
QUITY UPLC (Waters) coupled to a high-resolution maXis
II QTOF mass spectrometer equipped with CaptiveSpray
nanoBooster ionization source (Bruker). Peptides were sepa-
rated using gradient elution on a 25-cm Waters Peptide
BEH C18 nanoACQUITY 1.7 μm particle size UPLC col-
umn. Data were processed using proteinScape 3.0 software
(Bruker). Proteins were identified using Mascot (version 2.5,
Matrix Science) search engine against the Swissprot Mus
musculus database (accessed on 09/2017). The following pa-
rameters were used: trypsin enzyme, 7 ppm peptide mass
tolerance, 0.05Da fragment mass tolerance, two missed
cleavages. Carbamidomethylation was set as fixed modifica-
tion, while deamidation (NQ) and oxidation (M) as variable
modifications. Proteins with a minimum of two identified,
unique peptides were accepted. Gene ontology enrichment
was performed using g:Profiler [30]. Label-free quantification
was performed using MaxQuant [31] software version
1.5.3.30. Each LC-MS/MS run was aligned using the “match
between runs” feature (match time window 0.8min, align-
ment time window 15min).
Silencing IFITM3 by lentiviral particle containing shRNA
The commercially available lentiviral particles (Santa-Cruz)
were named as sh-IFITM3 or sh-control (scrambled). Re-
combinant lentiviral vectors expressing IFITM3 shRNA or
control shRNA constructs at multiplicity of infection
(MOI) = 50 were transduced in the presence of 8 μg/ml
polybrene into freshly isolated BM cells. Knockdown of
IFITM3 RNA was confirmed by qRT-PCR and on protein
level with flow cytometry. Total RNA was extracted from
BM cells 2 days after infection using the RNeasy Mini Kit
(Qiagen). cDNA was synthesized using the SensiFAST
cDNA Synthesis Kit (Bioline). Real-time quantitative
PCR analysis was performed using the SYBR Green
Master Mix Kit (Bioline) on a 7900HT real-time
PCR platform (Thermo Fisher Scientific). For relative
quantification, 2-ΔΔCT was calculated. The primer se-
quences for PCR amplification of the IFITM3 gene
were 5′-TGTCCAAACCTTCTTCTCTCC-3′ and 5′-
CGTCGCCAACCATCTTCC-3′. GAPDH was applied
as an internal control.
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Statistics
Survival rates were analyzed by the Kaplan-Meyer test.
Data from > 3 groups were analyzed by non-repeated
measures ANOVA with Dunnett’s test for comparison
with the control. Unpaired two-tailed Student’s t test
was used to analyze data between two groups. For all
data analysis, we used GraphPad Prism 8.0.2.
Results
Radioprotective effect of RD-LPS
In the present study, we addressed the question whether
radio-detoxified LPS (RD-LPS) has a protective role if
administered i.p. 1 h after local thorax irradiation (IR) of
mice (Fig. 1a). As shown in Fig. 1b, most mice died
between days 133–169 post-irradiation. The median
survival was 141 days in the 16-Gy-irradiated group and
180 days in the irradiated and RD-LPS-treated mice (log-
rank Mantel-Cox test, p < 0.001). In C57Bl/6 mice, the
number of PBMCs decreased in the heart-irradiated
groups 24 h, and 1 week post-irradiation, the number of
BMCs decreased at 24 h in the RD-LPS+16 Gy groups and
1 week post-irradiation in the RD-LPS group (Add-
itional file 1). The 16-Gy-treated animals developed bilat-
eral ventricular hypertrophy as evidenced by gravimetry
after 250 days, but RD-LPS protected against radiation-
induced myocyte hypertrophy (Additional file 2). Hearts
of irradiated and RD-LPS-treated mice were further exam-
ined for evidence of pathologic alterations [32]. Van Gie-
son staining showed slight interstitial fibrosis in the
irradiated heart 250 days after 16 Gy and RD-LPS+16 Gy
(Fig. 1c). Quantitative analysis of the images indicated a
significant increase of myocyte size 250 days after 16Gy
(p < 0.001) and RD-LPS+16Gy (p < 0.05) compared with
control mice (Fig. 1d). Mitochondrial DNA deletion, as a
molecular marker of cardiomyocyte damage was assessed
[33]. The results showed that the formation of mtDNA
deletion in early and late time points in the irradiated
groups was higher than in the controls, but this difference
was significant only at 250 days post-irradiation (p < 0.05).
Preventive effect of RD-LPS was also detected (Fig. 1e).
RD-LPS enhances the mobility and migration of EPCs
Next, we set to examine the number of EPCs in the BM
of experimental groups of mice. As shown in Fig. 1f, the
number of EPCs was higher in the groups of mice
injected with RD-LPS with or without irradiation as
compared to the PBS-injected controls (p < 0.001 for
both groups). We also analyzed EPCs in blood samples
of mice and also found a significant difference between
the above groups (p < 0.001 and p < 0.005, respectively,
see Fig. 1g). Since RD-LPS stimulated the differentiation
and also the release of EPCs into the circulation, we
speculated that RD-LPS may promote the survival of
BM stem cells and the uptake of ac-LDL by EPCs. To
test this, isolated BMCs were treated with RD-LPS for
24 h and the apoptosis of lineage-negative stem cells
were measured by flow cytometry. The proportion of
early apoptotic cells were 10.39 ± 1.6% in the control
group and 2.99 ± 0.7 in the RD-LPS group (p = 0.0002)
as shown in Fig. 2a and Additional file 3, while late
apoptosis (annexin V and TO-PRO positive cells) did
not show significant differences (data not shown).
Next, BM cells were cultured in an endothelial induction
medium (EGM2, Lonza) to obtain endothelial progenitor
cells. To identify the resulting EPCs, we measured surface
markers CD34 and VEGFR2 and the expression of endo-
thelial specific mRNAs CD31 and VE-cadherin and also
investigated the physiologic functions of these cells by
monitoring DiI-labeled acetylated LDL (DiI-ac-LDL) endo-
cytosis [34]. Following in vitro treatment with RD-LPS,
EPCs were incubated for 4 h with DiI-ac-LDL and cell-
associated fluorescence was analyzed by fluorescence mi-
croscopy (Zeiss Celldiscoverer, Additional file 4, panels A-
C) and quantitated by flow cytometry. As shown in Fig. 2b,
treatment with RD-LPS led to a significant increase in
cell association (a combination of binding and uptake)
of DiI-ac-LDL. To investigate the effects of RD-LPS
on EPC, the biological factors associated with matured
endothelial cells were measured by real-time RT-PCR.
The expression of two markers (CD31 and VE-cadherin)
were elevated in the RD-LPS-treated group as compared
to the PBS group (Additional file 4, panels D-E). CD31 in-
creased by 3.89 ± 0.5 fold, whereas VE-cadherin increased
by 10.68 ± 3.8 fold.
Effect of RD-LPS on BM-derived small extracellular vesicles
Subsequently, we examined whether blocking the gener-
ation of sEVs would modulate the RD-LPS-induced EPC
response. To delineate the possible involvement of sEVs
in the RD-LPS-induced changes in EPC numbers, we in-
vestigated the in vivo effects of GW4869. GW4869 is a
neutral sphingomyelinase inhibitor reported to inhibit
the ESCRT-independent sEV biogenesis [35]. Indeed,
GW4869 attenuated the RD-LPS-induced increase in
EPC number in BM (Fig. 2c).
To confirm that BM cells secrete RD-LPS-induced
sEVs, we isolated sEVs from primary BMCs. Transmis-
sion electron microscopy (TEM) confirmed the presence
and morphology of the sEVs (Fig. 2d). Next, we analyzed
the particle size distribution and concentration of our
sEV-enriched preparations by TRPS. Figure 2e shows
representative size distribution of EVs from BMCs iso-
lated from control (upper histogram) and RD-LPS-
injected mice (lower histogram) which corresponded to
the size range of sEVs and did not differ between the ex-
perimental groups. Of note, RD-LPS induced an order of
magnitude higher number of EVs as compared to PBS
controls (Fig. 2e). Using flow cytometry, we confirmed
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Fig. 1 Effect of local chest irradiation and RD-LPS treatment. a A schematic illustration of the experimental setup. Hearts of C57BL/6 mice
received a 16-Gy single dose of X-ray radiation. b Kaplan-Meyer diagram shows the changes of survival in animals treated with PBS, PBS+16 Gy of
X-ray, RD-LPS (20 μg/mouse) or 16 Gy combined with RD-LPS (n = 9–10/group). p < 0.001, Log-rank Mantel-Cox test. c Representative images of
histopathologic changes at 250 days after local heart irradiation. Interstitial fibrosis and degeneration of cardiomyocytes after 16 Gy are indicated
(arrows). Van Gieson staining, × 20 objective magnification. Scale bar: 50 μm. d Morphometric analysis of cardiomyocyte cross-sectional area 250
days post-treatment. Original magnification × 20. Quantitative analysis of myocyte cross-sectional area is shown; *p < 0.05 and ***p < 0.005 vs.
PBS-treated animals. e RD-LPS protects against the radiation-induced accumulation of deleted mitochondrial DNA. Copy number was evaluated
with qPCR as detailed in “Materials and methods”. f Flow cytometry analysis of EPCs in the BMCs and g in the circulation. One-way ANOVA,
**p < 0.01; ***p < 0.001, n = 6–12/group. Mean ± SD values are shown
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Fig. 2 (See legend on next page.)
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the presence of sEV markers (CD81, CD9, CD63, and
CD107a) on our sEVs bound onto latex beads (Fig. 2f).
Next, to address the question which proteins could
play a role in the function of RD-LPS, we performed
mass spectrometry analysis of the isolated sEVs. We
identified 320 proteins in sEVs. Among them, 178 were
shared by EVs isolated from the conditioned medium of
BMCs from PBS-injected and RD-LPS-injected animals
(Fig. 2g, Additional file 5). We classified the identified
proteins using gene ontology (GO), based on biological
process, molecular process, and cellular function. The sEV
proteins were mainly involved in angiostatin binding (GO:
0043532) and positive regulation of blood vessel endothe-
lial cell migration (GO:0043536) (Additional file 6). Cellu-
lar components of the identified proteins revealed that
most proteins were related to EVs (GO:1903561) (Add-
itional file 6). We identified IFITM3 as a protein that
showed the highest (6.89×) fold change (Fig. 2h). Using an
ELISA system, we validated this MS finding (Fig. 3a). The
expression of IFITM3 was low in BMC sEVs of the
PBS-injected group, while it was enriched in sEVs in
the RD-LPS-injected mice (p > 0.05). Similar results
were measured from cells (data not shown). Figure 3b
shows that flow cytometry confirmed double (IFITM3
and CD81) positivity of the sEV-enriched preparation.
Effect of IFITM3 silencing on the activation of EPCs by
RD-LPS
The role of vesicular IFITM3 on RD-LPS-induced EPCs
was assessed by RNA silencing experiments. As shown
in Additional file 7, high expression levels of IFITM3
were observed in RD-LPS-treated BMCs in vitro. To ver-
ify that the IFITM3 gene was silenced by sh-IFITM3, we
determined the mRNA levels (Additional file 7A) in sh-
control (scrambled control) and sh-IFITM3-infected cells
by qRT-PCR. Cells infected with sh-IFITM3 exhibited
significantly decreased IFITM3 mRNA levels, showing a
69.8 ± 7.5% reduction. To confirm the silencing of
IFITM3, flow cytometry with IFITM3 antibodies was
used. Compared with sh-control-infected cells, the
IFITM3 protein level was significantly (89.2 ± 0.9%) de-
creased in BM cells infected with the sh-IFITM3 lenti-
virus (Additional file 7B). To determine whether
IFITM3 has any impact on the RD-LPS’s action, EPC
number was measured by flow cytometry and ac-LDL
uptake was analyzed in differentiated EPCs by fluores-
cent microscopy and quantified by flow cytometry. Our
data indicated that depletion of IFITM3 abolished the
RD-LPS induction on EPCs as compared to RD-LPS-
treated sh-control cells (2.77 ± 1.26% vs. 4.20 ± 0.79%,
see Additional file 8), suggesting that the reduced ex-
pression of IFITM3 could significantly inhibit the eleva-
tion of EPCs in BM. Reduction of IFITM3 blocked the
ac-LDL uptake in RD-LPS-treated cells compared to
sh-control cells (75.65 ± 0.8% vs. 81.18 ± 1.6%, see Add-
itional file 9). These results indicate that silencing of
IFITM3 by RNAi could inhibit the effect of RD-LPS on
induction of IFITM3 in BM cells.
Finally, to address the question if the IFITM3 cargo in
sEVs could play a role in the effect of RD-LPS, we treated
differentiated EPCs with the conditioned medium of sh-
IFITM3-transduced BM cells. Acetylated LDL uptake was
quantified in differentiated EPCs with flow cytometry
(Fig. 3c). Adding conditioned medium of RD-LPS-treated
BM cells to naive EPCs did not induce the further uptake
of ac-LDL in sh-control+RD-LPS cells compared with sh-
control cells (92.3 ± 0.4% vs. 91.2 ± 4.6%). However, down-
regulation of IFITM3 suppressed the activity of EPCs in
sh-IFITM3+RD-LPS groups to 78.2 ± 0.8% (see Fig. 3c),
indicating that IFITM3 modulates the function of differ-
entiated EPCs.
A graphical summary of the study is shown in Fig. 4.
Discussion
Breast cancer radiotherapy causes myocardial damage
and increases the risk of cardiovascular disease and ath-
erosclerosis [36]. The pathogenesis of radiation-induced
heart disease is not completely understood: since there
(See figure on previous page.)
Fig. 2 Effect of RD-LPS treatment viability and the function on EPCs. a RD-LPS protects against apoptosis of the lineage-negative stem cell
population in the BM. BMCs were isolated, labeled with annexin V-FITC and To-Pro3, and measured by flow cytometry. b RD-LPS stimulates
uptake of DiI-labeled ac-LDL by EPCs. Following 10 days of BMC culture in EBM-2 medium in the presence of vehicle PBS or 100 ng/ml RD-LPS,
EPCs were incubated for 4 h with 1 μg protein/ml DiI-ac-LDL, as described in the “Materials and methods”. Cell-associated fluorescence was
quantitated by flow cytometry. Each point represents the mean fluorescence of 10,000 cells. The experiment was repeated three times with
similar results, n = 6, ***: p = 0.0002. Investigation of the role of sEVs in in vivo RD-LPS response. c RD-LPS-stimulated EPC response of the BM was
abolished by in vivo GW4869 treatment (20 μg/mice), measured by flow cytometry (n = 5–6). One-way ANOVA, *p < 0.05 PBS vs. RD-LPS. Mean ±
SD values are shown. d–f The characterization of sEVs isolated from the conditioned media of BMCs. d Representative transmission electron
microphotographs (TEM) of sEVs isolated from the conditioned media of BMCs of PBS-injected (large image) and RD-LPS-injected mice (insert). e
Particle size distribution and concentration in the sEV-enriched preparations isolated from the conditioned media of BMCs determined by tunable
resistive pulse sensing (qNano). The upper and lower panels show representative profiles of sEVs in the PBS-injected and RD-LPS-injected groups,
respectively. f Flow cytometry analysis of BMC-derived sEVs. Representative results of three independent experiments are shown. g Venn diagram
of PBS control and RD-LPS-treated sEV proteome. The numbers of identified proteins are indicated. h Quantitative analysis of differentially
expressed proteins in RD-LPS and PBS samples. Fold change threshold is > 4. Green- and pink-labeled proteins are down- and
upregulated, respectively
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is no specific treatment for these complications, a pre-
vention strategy is required. Many ongoing pre-clinical
studies aim to elucidate molecular and cellular mecha-
nisms of cardiovascular damage, and their goal is to find
potential targets for intervention of cardiotoxicity [37].
Our data are in line with a previous study [38] showing
structural damage of the myocardium in C57BL/6 mice
after local heart irradiation. Although radiation induced
only modest changes in cardiomyocyte morphology and
radiation-induced mitochondrial DNA deletion, these
were mitigated by RD-LPS. However, a single local heart
dose of 16 Gy resulted in reduced survival, and RD-LPS
was protective against sudden death. Similar results were
presented in dog models [39]. Since the endothelium of
the vasculature is thought to be one target for injury in-
duced by radiation, pharmaceutical approaches to pre-
vent radiation-related cardiac injury present a potential
method to mitigate and treat these types of damages.
Not surprisingly, there has been intense interest in car-
diac injury-mitigating therapeutic cell transplants; how-
ever, the major problems with this strategy have been
the poor engraftment and retention of the administered
cells [40]. Activating adult stem or progenitor cells may
hold more promise as a therapeutic intervention strategy
for vascular regeneration [41]. BM-derived EPCs have
been implicated in the repair of irradiation-induced
damage of capillaries via their mobilization into circula-
tion [42]. In the present study, we aimed to investigate
Fig. 3 Validation of the expression and function of IFITM3 in BMC-derived sEVs. a Data (mean ± SD) measured using ELISA (n = 5). Unpaired
Student’s t test, *p < 0.05. b BMC-derived sEVs from PBS- or RD-LPS-treated mice were stained with anti-CD81 and anti-IFITM3 and were analyzed
by flow cytometry. Within Q2 quadrants, numbers indicate the relative percentages of positive cells. Double (CD81 and IFITM3) positive sEVs are
shown by arrows. Left: isotype control, middle: PBS-injected group and right: RD-LPS group. c Loss of IFITM3 reduces BM-derived sEV-mediated
modulation of function of EPCs. Differentiated EPCs were treated with the conditioned medium either of sh-control-transduced BMCs or sh-
control-transduced and RD-LPS-treated BMCs or sh-IFITM3-transduced and RD-LPS-treated BMCs. DiI-ac-LDL uptake was measured by flow
cytometry, the measurements were repeated three times, and the panel shows mean ± SD, **p < 0.01
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how RD-LPS impacts the release of EPCs from the BM
into the circulation and if RD-LPS could play a protect-
ive role in irradiation-induced mortality of mice. We
demonstrated association of high EPC count with re-
duced cardiac hypertrophy and mitochondrial DNA
damage, which reinforces previous findings of their pro-
tective role in cardiovascular damage [43]. Our data sug-
gest that in RD-LPS-treated mice EPCs proliferate and
migrate, increasing their number in the circulation.
Thus, RD-LPS treatment could have a future impact as an
initiating factor triggering EPCs. In this model, we obtained
the beneficial effect of RD-LPS on survival and the
treatment-associated increase of the endogenous EPCs.
Several pre-clinical models have demonstrated mobilization
and migration of EPCs from the bone marrow niche
followed by homing to the site of vascular damage, where
they modulated vascular repair [44]. Endogenous factors
used therapeutically, like granulocyte colony-stimulating
factor (G-CSF) and GM-CSF, are also known to induce
BM-EPC mobilization and migration but may present with
further complications [45]. RD-LPS has no known adverse
side effects and therefore may be a promising therapeutic
agent for vascular regeneration.
In an earlier study, we have shown that a low-dose local
head irradiation caused cerebrovascular damage and de-
creased the ability of endothelial repair by circulating pro-
genitors [46]. In addition, in a mouse model of total body
irradiation, administration of G-CSF improved the
survival, presumably via promoting the self-renewal of
hematopoietic stem cells [47]. Radioprotective action of
RD-LPS has been confirmed in several in vitro and in vivo
models [9, 48], but it has not been tested in cardiotoxicity
mouse models yet. It is accepted that radiation damages
the vascular endothelial cells [38] allowing the system-
wide translocation of endotoxin from intestinal bacteria.
The LPS then, among other adverse effects, induces in-
flammation associated with cardiotoxicity [49]. Here we
found that radiation-detoxified LPS protects against
radiation-induced lethality in 16-Gy-exposed mice and in-
duced release of EPCs. Indeed RD-LPS reduced the apop-
tosis of the stem cells in the BM and induced the
differentiation of the EPC culture in vitro. One of the pos-
sible mechanisms of the life-extending beneficial effects of
RD-LPS could be that it antagonizes radiation-induced ad-
verse effects of LPS by blocking its receptor.
The ability of isolated EPCs to uptake acetylated low-
density lipoprotein (DiI-ac-LDL), the classical way to define
endothelial cells, was performed as described earlier [50].
Two types of EPCs can be distinguished at different time
points during in vitro differentiation: early and late EPCs
[51]. EPCs can take up DiI-ac-LDL and express various
combinations of surface markers of the endothelial cell
lineage [52]. Our cells were late EPCs with the expressed
matured endothelial-specific markers. EPCs at 10 days after
plating also show the cobblestone morphology typical of
endothelial cells (Additional file 4, panel C).
Fig. 4 Overview of RD-LPS-induced release of bone marrow-derived small EVs with IFITM3 cargo. C57/Bl mice were injected i.p. with RD-LPS.
After 24 h, the amount of EPCs (depicted as orange cells with gray nuclei) were elevated both in the bone marrow and peripheral blood,
potentially playing a role in the vascular regeneration of distant damaged tissues. Small EVs (dark pink dots) isolated from bone marrow cells
presented upregulated IFITM3 expression (light blue)
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RD-LPS induced the number of sEVs, and we hypothe-
sized that extracellular vesicles released from different
cells are putatively involved in different aspects of the
systemic response to RD-LPS, including paracrine and
bystander effects. EVs may also act as stable reservoirs
of biomarkers by containing specific cargo that reflect
the effect of RD-LPS. We also investigated the effects of
RD-LPS in vivo on the proteomic composition of BMC-
derived sEVs [53] and observed pronounced differences
in the protein profiles of BMC- and RD-LPS-injected
BMC-derived sEVs. RD-LPS-induced sEVs carried a dis-
tinct set of proteins. Among them, IFITM3 showed the
highest fold change as compared to the controls, validated
also by an IFITIM3 ELISA and flow cytometry analysis of
sEVs. This is in line with recent findings reporting
IFITM3 in sEVs mediating paracrine senescence [54].
IFITM3 is best known to play a role in the defense against
virus invasion and potentially inhibits EV fusion with cells
[55, 56]. Small extracellular vesicle-associated IFITM3 has
been also shown earlier to transfer an anti-viral effect to
recipient cells [57]. Interestingly, IFITIM3 is present in
migratory primordial germ cells and serves as a homing
signal enabling cells to respond to environmental signals
guiding their migration [58]. Recently, IFITIM3 has also
been reported as a biomarker of several tumors [59, 60].
Moreover, IFITM3 was detected in endothelial cells and
several cancer cell-derived sEVs by MS [61, 62]. We spec-
ulated that IFITM3 was necessary for the activation of dif-
ferentiated EPCs and RD-LPS-induced EPC activation
based on an early stem cell induction phase. Surprisingly,
in our in vitro experiments, the RD-LPS effect was not
transmitted through EVs. However, our data suggest that
the presence of IFITM3 in the cells is necessary for RD-
LPS-induced EPC activation, in agreement with a recent
study pinpointing the possible role of IFITM3 in glioma
cell growth and migration [63].
Our results suggest that the expression of the trans-
membrane protein IFITM3 is strongly upregulated in
RD-LPS-treated mice. In addition, IFITIM3 is associated
with BMC-derived sEVs and may provide a promising
candidate biomarker of the RD-LPS effect. Thus, assess-
ment of cellular and EV-associated IFITIM3 may pos-
sibly find a place among strategies for evaluating the
regeneration potential of BM.
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